FDA Enforcement Class II Ongoing

Nasopore Ex Firm 4cm fragmentable nasal dressing, Catalog Number 5400-030-004 and Nasopore Forte plus 4cm Catalog Number 5400-030-004ITL

Recall: Z-1478-2025 · Reported April 9, 2025

Enforcement

Recall Number
Z-1478-2025
Event ID
96393
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Stryker Corporation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
April 9, 2025
Initiation Date
February 25, 2025
Classification Date
March 28, 2025
Address
1941 Stryker Way, Portage, MI, 49002-9711, United States

Description

Nasopore Ex Firm 4cm fragmentable nasal dressing, Catalog Number 5400-030-004 and Nasopore Forte plus 4cm Catalog Number 5400-030-004ITL

Reason

There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.

Code Info

5400-030-004 UDI-DI: 07613154340835, Lot Numbers: 2024052333 2023012514 2023050514 2023080912 2024020214; 5400-030-004ITL UDI-DI: 07613327359442, Lot Numbers: 2023071933 2023102714 2024012314

Distribution

US Nationwide distribution.

Quantity

182,344 total units